Literature DB >> 7931164

Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species.

W Oualikene1, P Gonin, M Eloit.   

Abstract

As a first step in the evaluation of the safety of replication-defective adenoviruses used as gene transfer vectors, the dissemination of wild-type (wt) adenovirus (Ad) type 5, Ad-d1327 (deleted for the E3 gene) and Ad-gp50 (deleted for E3 and E1A and therefore replication defective) was studied in mice and cotton rats. Of each virus, 10(8) p.f.u. was inoculated, either by the intranasal or the intramuscular route, and virus isolation was undertaken after sacrifice of the animals 3 or 31 days after inoculation. E3 deletion had no significant effect on viral spread, whereas E1A deletion reduced it significantly. After intramuscular inoculation of the E3-/E1A- virus, it could be isolated only from the local lymph node. Intranasal inoculation led to a wider distribution including lungs, liver, kidneys and lymph nodes. The pattern of dissemination of the E3-/E1A- virus was the same in mice and cotton rats, providing indirect evidence of the lack of replication of this virus in this species permissive for the wt virus. However, in the case of infection with a wt strain in E3-/E1A- adenovirus-inoculated recipients, both viruses were found in lymph nodes. In this situation the risk of phenotypic complementation of the E1A gene remains to be studied further.

Entities:  

Mesh:

Year:  1994        PMID: 7931164     DOI: 10.1099/0022-1317-75-10-2765

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

2.  Productive replication of human adenoviruses in mouse epidermal cells.

Authors:  I Ganly; V Mautner; A Balmain
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 3.  Adenovirus-mediated gene transfer into striated muscles.

Authors:  G Acsadi; B Massie; A Jani
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

4.  Induction of mucosal immunity in cotton rats to haemagglutinin-esterase glycoprotein of bovine coronavirus by recombinant adenovirus.

Authors:  M E Baca-Estrada; X Liang; L A Babiuk; D Yoo
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

5.  New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.

Authors:  J F Spencer; J E Sagartz; W S M Wold; K Toth
Journal:  Cancer Gene Ther       Date:  2009-05-29       Impact factor: 5.987

6.  Lack of evidence of phenotypic complementation of E1A/E1B-deleted adenovirus type 5 upon superinfection by wild-type virus in the cotton rat.

Authors:  W Oualikene; P Gonin; M Eloit
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies.

Authors:  B Ying; K Toth; J F Spencer; J Meyer; A E Tollefson; D Patra; D Dhar; E V Shashkova; M Kuppuswamy; K Doronin; M A Thomas; L A Zumstein; W S M Wold; D L Lichtenstein
Journal:  Cancer Gene Ther       Date:  2009-02-06       Impact factor: 5.987

8.  Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.

Authors:  Hannah H Chen; Ryan Cawood; Yasser El-Sherbini; Laura Purdie; Miriam Bazan-Peregrino; Leonard W Seymour; Robert C Carlisle
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

9.  Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice.

Authors:  Pei-Hsin Cheng; Xiao-Mei Rao; Stephen L Wechman; Xiao-Feng Li; Kelly M McMasters; Heshan Sam Zhou
Journal:  BMC Cancer       Date:  2015-10-16       Impact factor: 4.430

Review 10.  Immunology of Adenoviral Vectors in Cancer Therapy.

Authors:  Amanda Rosewell Shaw; Masataka Suzuki
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-13       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.